Related Experiment Video
Updated: Aug 10, 2026

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
Mutational analysis of the cell cycle inhibitor Kip1/p27 in childhood leukemia
E-A Markaki1, E Stiakaki, A Zafiropoulos
1Department of Pediatric Hematology-Oncology, University of Crete, Medical School, Heraklion Crete, Greece.
Background:
Cyclin-dependent kinases (CDKs) and cyclins, their regulatory subunits, govern cell-cycle progression in eukaryotic cells. Kip1/p27 is the main cyclin-dependent kinase inhibitor, which arrests cell division inhibiting G1-S transition. Kip1/p27 seems to play a critical role in the pathogenesis of several human malignancies and its lower expression has been shown to correlate with a poor prognosis in adult solid tumors.
Methods:
Bone marrow blasts from 49 children with leukemia, 37 acute lymphoblastic leukemia (ALL), and 12 acute myeloid leukemia (AML) were studied. Exon 3 of Kip1/p27 was amplified using the polymerase chain reaction technique (PCR). Single strand conformational polymorphism and heterodouplex analysis were performed to detect DNA sequence with altered conformations and were subsequently sequenced to document mutations.
Results:
Mutations in Kip1/p27 gene were detected in 2 out of 3 T-ALL, 6 out of 12 AML patients, and only 1 out of 34 B lineage ALL cases. Although the patient groups are small, a highly significant relation of the mutation status with the type of leukemia (P = 0.0037) and the risk group according to treatment protocols (P = 0.00021) was estimated. A statistically significant difference in the white blood count was observed (P = 0.019) between the mutated and non-mutated patient groups although no statistically significant association of the mutation status with the hemoglobin and platelets values, karyotype, age, sex, disease progression, and outcome was determined.
Conclusions:
Based upon these results, the Kip1/p27 mutations should be considered for further prospective testing as an additional parameter for risk stratification and treatment of childhood leukemia.
Insights
Mutations in the Kip1/p27 gene were found in childhood leukemia, particularly in T-cell acute lymphoblastic leukemia and acute myeloid leukemia. These Kip1/p27 mutations correlate with leukemia type and risk group, suggesting their use in risk stratification.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Cyclin-dependent kinases (CDKs) regulate cell-cycle progression.
- Kip1/p27 is a key inhibitor of cell division, crucial in preventing G1-S transition.
- Reduced Kip1/p27 expression is linked to poor prognosis in adult solid tumors.
Purpose of the Study:
- To investigate mutations in the Kip1/p27 gene in pediatric leukemia.
- To determine the correlation of Kip1/p27 mutations with leukemia subtypes and clinical parameters.
Main Methods:
- Bone marrow samples from 49 children with leukemia (37 ALL, 12 AML) were analyzed.
- Polymerase chain reaction (PCR) amplified Exon 3 of the Kip1/p27 gene.
- Single strand conformational polymorphism and heterodouplex analysis detected DNA sequence alterations, followed by sequencing.
Main Results:
- Kip1/p27 gene mutations were identified in 2/3 T-ALL, 6/12 AML, and 1/34 B-ALL cases.
- Mutation status significantly correlated with leukemia type (P=0.0037) and risk group (P=0.00021).
- A significant difference in white blood cell count was observed between mutated and non-mutated groups (P=0.019).
Conclusions:
- Kip1/p27 mutations are present in childhood leukemia, particularly T-ALL and AML.
- These mutations show a significant association with leukemia type and risk stratification.
- Kip1/p27 mutations warrant further investigation as a prognostic marker for childhood leukemia treatment.
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Positive Regulator Molecules

